IRIS
GUIDO, MAURIZIO
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 4.483
AS - Asia 2.225
EU - Europa 1.904
SA - Sud America 451
AF - Africa 46
OC - Oceania 3
Totale 9.112
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 4.396
SG - Singapore 1.262
RU - Federazione Russa 636
IE - Irlanda 576
BR - Brasile 380
HK - Hong Kong 283
CN - Cina 265
VN - Vietnam 186
DE - Germania 180
IT - Italia 146
GB - Regno Unito 70
FI - Finlandia 57
IN - India 55
CA - Canada 48
FR - Francia 44
JP - Giappone 33
SE - Svezia 29
AR - Argentina 28
CZ - Repubblica Ceca 27
PL - Polonia 26
NL - Olanda 24
BD - Bangladesh 23
MX - Messico 23
BE - Belgio 19
IQ - Iraq 18
ES - Italia 15
EC - Ecuador 12
TR - Turchia 12
ZA - Sudafrica 12
AT - Austria 10
KR - Corea 10
AE - Emirati Arabi Uniti 8
ID - Indonesia 8
SA - Arabia Saudita 8
VE - Venezuela 8
CO - Colombia 7
LT - Lituania 7
MA - Marocco 7
EG - Egitto 6
OM - Oman 6
PK - Pakistan 6
TN - Tunisia 6
AZ - Azerbaigian 5
BG - Bulgaria 5
CL - Cile 5
IL - Israele 5
UY - Uruguay 5
AL - Albania 4
BO - Bolivia 4
EE - Estonia 4
JM - Giamaica 4
NP - Nepal 4
UZ - Uzbekistan 4
AU - Australia 3
KE - Kenya 3
KG - Kirghizistan 3
KZ - Kazakistan 3
PH - Filippine 3
RO - Romania 3
RS - Serbia 3
TW - Taiwan 3
CH - Svizzera 2
CR - Costa Rica 2
DK - Danimarca 2
DO - Repubblica Dominicana 2
ET - Etiopia 2
HN - Honduras 2
IR - Iran 2
LB - Libano 2
MK - Macedonia 2
NO - Norvegia 2
TH - Thailandia 2
UA - Ucraina 2
BN - Brunei Darussalam 1
BS - Bahamas 1
BY - Bielorussia 1
BZ - Belize 1
CG - Congo 1
CI - Costa d'Avorio 1
GA - Gabon 1
GL - Groenlandia 1
GM - Gambi 1
GQ - Guinea Equatoriale 1
GR - Grecia 1
HR - Croazia 1
HU - Ungheria 1
JO - Giordania 1
KH - Cambogia 1
LU - Lussemburgo 1
LY - Libia 1
MD - Moldavia 1
MT - Malta 1
MW - Malawi 1
NG - Nigeria 1
NI - Nicaragua 1
PA - Panama 1
PE - Perù 1
PS - Palestinian Territory 1
PT - Portogallo 1
PY - Paraguay 1
Totale 9.106
Salva come PNG Salva come JPEG
Città #
Dallas 700
Singapore 666
Dublin 568
Chandler 556
San Jose 491
Ashburn 352
Hong Kong 279
Santa Clara 264
The Dalles 142
Jacksonville 140
Boardman 133
New York 112
Moscow 105
Los Angeles 96
Lawrence 82
Princeton 82
Wilmington 81
Des Moines 71
Columbus 67
Ho Chi Minh City 66
Munich 66
Falkenstein 57
Beijing 52
San Mateo 47
Council Bluffs 43
Ann Arbor 37
Hanoi 36
Falls Church 34
Tokyo 32
Lauterbourg 30
São Paulo 28
Rome 27
Warsaw 25
Helsinki 24
Orem 24
Frankfurt am Main 22
Brno 19
Brussels 19
L’Aquila 17
Toronto 17
Turku 17
Chennai 16
Montreal 16
Poplar 16
Stockholm 15
Amsterdam 14
Denver 14
Lappeenranta 14
Atlanta 13
Hefei 13
Mumbai 13
Brasília 12
Chicago 12
Norwalk 12
Da Nang 11
San Francisco 11
Brooklyn 10
Curitiba 10
Manchester 10
Seoul 10
Shanghai 10
Assago 9
Bremen 9
London 9
Rio de Janeiro 9
Belo Horizonte 8
Boston 8
Haiphong 8
Johannesburg 8
Ravenna 8
Baghdad 7
Düsseldorf 7
Hanover 7
Seattle 7
Gioiosa Ionica 6
Jakarta 6
Mexico City 6
Phoenix 6
Ankara 5
Baku 5
Betim 5
Bristol 5
Bắc Ninh 5
Campinas 5
Charlotte 5
Houston 5
Milan 5
Montevideo 5
Olomouc 5
Pittsburgh 5
Pune 5
Quito 5
Sofia 5
Vienna 5
Birmingham 4
Erbil 4
Guayaquil 4
Muscat 4
New Delhi 4
Salvador 4
Totale 6.210
Salva come PNG Salva come JPEG
Nome #
"Evaluation of extracellular vesicle-associated TGF-β as a biomarker in patients with endometriosis" in Meeting abstracts of the 3° EVIta symposium 142
Case report: incomplete Cauda Equina Syndrome following a caesarean section with spinal anaesthesia 140
Perinatal mental illness and autoimmune diseases: a qualitative sistematic review 136
Factors associated with chronic pelvic pain in women with endometriosis: A national study on clinical and sociodemographic characteristics, lifestyles, quality of life, and perceptions of quality of care, during the COVID-19 pandemic 135
Sex ratio at birth: causes of variation and narrative review of literature 133
Investigating Unhealthy Behaviors Associated with SF-36 Domains in Women with Endometriosis—Findings from a Web-Based Survey Data Set 132
Haemorrhoidal disease in pregnancy: results from a self-assessment questionnaire administered by means of a social network 131
A first stage placental site trophoblastic tumor: a case report and review of literature 126
Recurrent Metastatic Pulmonary Synovial Sarcoma during Pregnancy: A Case Report and Literature Review 125
The Impact of Metal Nanoparticles on Female Reproductive System: Risks and Opportunities 125
AGEs-related dysfunctions in PCOS: evidence from animal and clinical research 123
Acute insulin response to intravenous glucagon in polycystic ovary syndrome 120
Sonographic features of pelvic tuberculosis mimicking ovarian-tubal-peritoneal carcinoma 114
Effect of gonadotropin-releasing hormone agonist treatment on growth hormone responses in women with polycystic ovary syndrome 111
Synchronous ovarian and uterine tumours, case report of an unusual association 110
Pre-eclampsia: From Etiology and Molecular Mechanisms to Clinical Tools. A Review of the Literature 107
Differential androgen response to adrenocorticotropic hormone stimulation in polycystic ovarian syndrome: Relationship with insulin secretion 107
ROLE OF VOCAL DISTRACTION ANALGESIA ON PAIN MANAGEMENT IN THE OFFICE HYSTEROSCOPY PROCEDURE: A RANDOMIZED CONTROLLED STUDY 105
Botulinum toxin in incontinent women with neurogenic bladder after failure with anticholinergic therapy, long-term results: a pilot study 104
The Accuracy of Third-Trimester Ultrasound in Predicting Large for Gestational Age or Macrosomic Fetuses in Diabetic and Non-Diabetic Pregnant Women: A Systematic Review and Meta-Analysis 103
Asymptomatic postmenopausal endometrial thickening: a comparison between transvaginal ultrasound and hysteroscopy in the diagnosis of intracavitary uterine pathologies 101
Second stimulation in the same ovarian cycle: an option to fully-personalize the treatment in poor prognosis patients undergoing PGT-A 100
Carbon dioxide in office diagnostic hysteroscopy: An open question. A multicenter randomized trial on 1982 procedures 99
The Perception of the Quality of Professional Healthcare Assistance for the Management of Endometriosis: Findings from a National Survey in Italy 97
Late third trimester diagnosis of congenital giant hemangioma complicated by the Kasabach-Merritt phenomen: a case report and literature review 97
Ultrasound Features and Clinical Outcome of Patients with Ovarian Masses Diagnosed during Pregnancy: Experience of Single Gynecological Ultrasound Center 95
Risk Assessment Model for Complications in Minimally Invasive Hysterectomy: A Pilot Study 95
Role of opioid antagonists in the treatment of women with glucoregulation abnormalities 92
Sonographic characteristics of ovarian Leydig cell tumor 91
The metabolic status modulates the effect of metformin on the antimullerian hormone-androgens-insulin interplay in obese women with polycystic ovary syndrome 90
COVID-19 and ART: the view of the Italian Society of Fertility and Sterility and Reproductive Medicine 90
How should the best human embryo in vitro be? Current and future challenges for embryo selection 88
Suppression and recovery of gonadotropin and steroid secretion by a gonadotropin-releasing hormone receptor antagonist in healthy women with normal ovulation versus women with polycystic ovary syndrome in the early follicular phase 88
Changes in luteinizing hormone and insulin secretion in polycystic ovarian syndrome 88
Conservative Management and Ultrasound Follow-Up of Parasitic Myoma: Our Experience and Literature Review 87
The accuracy of prenatal cell-free DNA screening for sex chromosome abnormalities: a systematic review and meta-analysis 86
A pilot study of the long-term effects of acipimox in polycystic ovarian syndrome 86
Effects of ghrelin administration on endocrine and metabolic parameters in obese women with polycystic ovary syndrome 86
The resting metabolic rate in women with polycystic ovary syndrome and its relation to the hormonal milieu, insulin metabolism, and body fat distribution: a cohort study 85
Effect of corticotropin-releasing factor on the pituitary-ovary axis in human luteal phase 85
Influence of body mass on the hypothalamic-pituitary-adrenal-axis response to naloxone in patients with polycystic ovary syndrome 84
The Italian guidelines on non-invasive and invasive prenatal diagnosis: Executive summary of recommendations for practice the Italian Society for Obstetrics and Gynecology (SIGO) 83
Naltrexone effect on pulsatile GnRH therapy for ovulation induction in polycystic ovary syndrome: A pilot prospective study 83
Administration of exogenous ghrelin in obese patients with polycystic ovary syndrome: effects on plasma levels of growth hormone, glucose, and insulin 83
Comparison of absorbable and permanent sutures for laparoscopic sacrocervicopexy: A randomized controlled trial 82
Effect of metformin on the growth hormone response to growth hormone-releasing hormone in obese women with polycystic ovary syndrome 82
Using a 16-french resectoscope as an alternative device in the treatment of uterine lesions: A randomized controlled trial 82
Is there a role for soy isoflavones in the therapeutic approach to polycystic ovary syndrome? Results from a pilot study 82
How metformin acts in PCOS pregnant women: Insights into insulin secretion and peripheral action at each trimester of gestation 81
The effect of age on the ovarian response to gonadotropin and on pregnancy rate in polycystic ovary syndrome 81
Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles 81
Vaginal mesh exposure after laparoscopic sacrocervicopexy performed with permanent or absorbable sutures 81
Metformin vs myoinositol: which is better in obese polycystic ovary syndrome patients? A randomized controlled crossover study 80
Ethinylestradio-chlormadinone acetate combination for the treatment of hirsutism and hormonal alterations of normal-weight women with polycystic ovary syndrome: Evaluation of the metabolic impact 79
Metformin improves endothelial function in normoinsulinemic PCOS patients: A new prospective 79
Erratum: Gonadotropin-releasing hormone agonist versus human chorionic gonadotropin as a trigger of ovulation in polycystic ovarian disease gonadotropin hyperstimulated cycles (Fertility and Sterility (1994) 62 (35- 41)) 79
Is the PCOS diagnosis solved by ESHRE/ASRM 2003 consensus or could it include ultrasound examination of the ovarian stroma? 79
DTC chemotherapy regimen is associated with higher incidence of premature ovarian failure in women of reproductive age with breast cancer 78
Evidence of a disturbance of the hypothalamic-pituitary-adrenal axis in polycystic ovary syndrome: Effect of naloxone 78
Conservative management of preterm premature rupture of membranes < 30 weeks of gestational age: Effectiveness of clinical guidelines implementation strategies 77
Tertiary Cytoreduction for Isolated Lymphnode Recurrence (ILNR) Ovarian Cancer in a BRCA2 Mutated Patient: Our Experience and Prevalence of BRCA 1 or 2 Genes Mutational Status in ILNR 77
Opioid blockade effect on insulin β-cells secretory patterns in polycystic ovary syndrome. Oral glucose load versus intravenous glucagon bolus 77
Impact of insulin and body mass index on metabolic and endocrine variables in polycystic ovary syndrome 77
Assessment of insulin resistance in lean women with polycystic ovary syndrome 76
Laparoscopic sacrocolpopexy versus pelvic organ prolapse suspension for surgical management of pelvic organ prolapse: a retrospective study 76
Follicular loss in endoscopic surgery for ovarian endometriosis: Quantitative and qualitative observations 75
Involvement of ovarian steroids in the opioid-mediated reduction of insulin secretion in hyperinsulinemic patients with polycystic ovary syndrome 75
Giant rapidly involuting congenital haemangioma and Kasabach-Merritt phenomenon: A potentially underhanded trap 74
The Impact of Thyroid Function on Human Reproduction: A Comprehensive Mini-Review 74
Alteration of ghrelin-neuropeptide Y network in obese patients with polycystic ovary syndrome: Role of hyperinsulinism 74
Preconceptional and gestational evaluation of insulin secretion in patients with polycystic ovary syndrome 74
Somatostatin treatment reduces the exaggerated response of adrenocorticotropin hormone and cortisol to corticotropin-releasing hormone in polycystic ovary syndrome 74
Position paper on prevention of surgical site infections in obstetric and gynecological surgery 74
Endocrinology: Effect of opioid blockade on insulin metabolism in polycystic ovarian disease 73
Differentiation of spermatogenic cells during in-vitro culture of testicular biopsy samples from patients with obstructive azoospermia: Effect of recombinant follicle stimulating hormone 73
Hypothalamic-pituitary-adrenal axis sensitivity to opioids in women with polycystic ovary syndrome 73
Perimesencephalic Subarachnoid Hemorrhage in Pregnancy 72
Expectant management may reduce overtreatment in women affected by unexplained infertility confirmed by diagnostic laparoscopy 69
Effect of pioglitazone treatment on the adrenal androgen response to corticotrophin in obese patients with polycystic ovary syndrome 69
Human spermatogenesis in vitro: Respective effects of follicle- stimulating hormone and testosterone on meiosis, spermiogenesis, and sertoli cell apoptosis 69
Metformin effects on ovarian ultrasound appearance and steroidogenic function in normal-weight normoinsulinemic women with polycystic ovary syndrome: A randomized double-blind placebocontrolled clinical trial 69
Fertility preservation methods in breast cancer 69
Longitudinal metabolic observation of metformin effects during pregnancy in hyperinsulinemic women with polycystic ovary syndrome: A case report 69
Clinical efficacy andmetabolic impact of two different dosages of ethinyl-estradiol in association with drospirenone in normal-weight women with polycystic ovary syndrome: A randomized study 68
How to improve MRI accuracy in detecting deep infiltrating colorectal endometriosis: MRI findings vs. laparoscopy and histopathology 68
Metformin treatment does not affect total leptin levels and free leptin index in obese patients with polycystic ovary syndrome 68
Evaluation of ovarian and adrenal sources of androgens in women with polycystic ovary syndrome: Dexamethasone and GnRH-agonist administration 67
Drospirenone for the treatment of hirsute women with polycystic ovary syndrome: A clinical, endocrinological, metabolic pilot study 67
Metaphase‑II oocyte competence is unlinked to the gonadotrophins used for ovarian stimulation: a matched case–control study in women of advanced maternal age 66
The link between metabolic features and TSH levels in polycystic ovary syndrome is modulated by the body weight: An euglycaemic-hyperinsulinaemic clamp study 66
Favorable conception and pregnancy involving a male patient affected by chronic myeloid leukemia while taking dasatinib 66
Sexual Function following Laparoscopic versus Transvaginal Closure of the Vaginal Vault after Laparoscopic Hysterectomy: Secondary Analysis of a Randomized Trial by the Italian Society of Gynecological Endoscopy Using a Validated Questionnaire 66
Selective effects of pioglitazone on insulin and androgen abnormalities in normo- and hyperinsulinaemic obese patients with polycystic ovary syndrome 66
Hyperinsulinemia in PCOS. Possible role in the determination of the ovary response to gonadotrophins 65
The Role of Anti-Müllerian Hormone in the Characterization of the Different Polycystic Ovary Syndrome Phenotypes 64
Role of opioid tone in the pathophysiology of hyperinsulinemia and insulin resistance in polycystic ovarian disease 64
The use of different size-hysteroscope in office hysteroscopy: Our experience 63
The I-KAPCAM-AI-Q: a novel instrument for evaluating health care providers’ AI awareness in Italy 62
Pioglitazone reduces the adrenal androgen response to corticotropin-releasing factor without changes in ACTH release in hyperinsulinemic women with polycystic ovary syndrome 62
Nerve-Sparing Laparoscopic Colposacropexy Using a Percutaneous Surgical System: A Case Report 61
Totale 8.660
Salva come PNG Salva come JPEG
Categoria #
all - tutte 43.633
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 43.633
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021120 0 0 0 0 0 0 0 0 0 2 117 1
2021/2022425 0 4 3 9 32 35 9 32 41 32 37 191
2022/20231.675 122 116 35 162 78 194 27 126 699 11 83 22
2023/2024480 71 17 43 34 33 110 22 35 3 51 22 39
2024/20252.450 53 48 174 148 298 280 331 125 553 107 162 171
2025/20264.001 210 344 600 518 518 247 687 156 323 398 0 0
Totale 9.296